Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight
Aveanna Healthcare (AVAH) reported Q2 revenue of $670M, up 13.7% YoY, with all divisions growing. CEO Shaner announced a pediatric nursing rate increase in California starting 2027. Adjusted EBITDA rose 8% to $95.4M. The company raised full-year guidance to over $2.68B in revenue and $365M in adjusted EBITDA. However, private duty services saw higher costs per hour, and some growth was due to nonrecurring items.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise expectations for continued growth, but margin pressure from labor costs and integration risk remain.
Market read
Positive earnings surprise and new rate relief could drive AVAH stock higher, while cost pressures warrant caution.
What to watch
Integration risk of the Family First Homecare acquisition and pending Medi‑Cal details could delay benefits.
Background
Aveanna Healthcare reported Q2 results with significant revenue growth and announced a California pediatric rate increase after a four‑year effort.
Ticker impact
Q2 earnings call disclosed 13.7% YoY revenue growth, $2.68B FY guidance and California rate increase impact.
Potential price rally of 5-10% on the back of improved outlook.
Revenue and EBITDA beat expectations; new rate relief and payer agreements support future growth.
Market effects
Home health and hospice sector may see broader valuation uplift from state rate wins.
California's rate increase could set precedent for other states, benefiting regional providers.
Limited to U.S. home‑health market; minimal global impact.
Counterpoint
Rising labor costs in private duty services may erode margins despite revenue growth.
Key entities
- companyAveanna Healthcare
Provider of home health, hospice, and private duty nursing services.
- governmentCalifornia Medi‑Cal
State program implementing the new pediatric private duty nursing rate.
